Patent · US Active

Injectable self-assembling antibacterial peptide hydrogels

US10632172B2 · kind B2 · utility

2Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2019
Grant dateApr 28, 2020
Priority date
Expiry dateJun 12, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A set of cationic amphiphilic self-assembled peptides (CASPs) is presented that employ high-charge density at fiber edges to disrupt bacterial membranes. CASP nanofibers are effective against Pseudomonas biofilms. There is an inherent trade-off between the ability of the peptides to undergo nanofibrous self-assembly and having a high terminal charge density required for effective bactericidal efficacy. The self-assembled peptide hydrogel presented achieves a balance of these opposing factors. Also demonstrated is the applicability of the new composition in an injectable hydrogel formulation. A CASP platform may be useful for topical application and integration into medical coatings, grafts, devices, and prostheses, thereby reducing risk of bacterial infection and related failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.